Business Description
Sanara MedTech Inc
NAICS : 333314
SIC : 3843
ISIN : US98211X1063
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -40.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 5.88 | |||||
Beneish M-Score | -2.66 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 42.4 | |||||
3-Year EBITDA Growth Rate | 63.5 | |||||
3-Year EPS without NRI Growth Rate | -3.9 | |||||
3-Year FCF Growth Rate | 24.6 | |||||
3-Year Book Growth Rate | 75.2 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.79 | |||||
9-Day RSI | 33.97 | |||||
14-Day RSI | 35.83 | |||||
6-1 Month Momentum % | 34.59 | |||||
12-1 Month Momentum % | -11.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.37 | |||||
Days Inventory | 196.55 | |||||
Days Sales Outstanding | 40.8 | |||||
Days Payable | 75.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.7 | |||||
Shareholder Yield % | -2.65 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 87.92 | |||||
Operating Margin % | -11.79 | |||||
Net Margin % | -6.62 | |||||
FCF Margin % | -5.4 | |||||
ROE % | -10.07 | |||||
ROA % | -6.55 | |||||
ROIC % | -15.78 | |||||
ROC (Joel Greenblatt) % | -95.64 | |||||
ROCE % | -7.39 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.06 | |||||
PB Ratio | 6.06 | |||||
EV-to-EBIT | -70.94 | |||||
EV-to-EBITDA | -976.37 | |||||
EV-to-Revenue | 4.33 | |||||
EV-to-FCF | -80.09 | |||||
Price-to-Median-PS-Value | 1.56 | |||||
Earnings Yield (Greenblatt) % | -1.41 | |||||
FCF Yield % | -1.28 |